VENOUS THROMBOEMBOLISM (VTE)
Clinical trials for VENOUS THROMBOEMBOLISM (VTE) explained in plain language.
Never miss a new study
Get alerted when new VENOUS THROMBOEMBOLISM (VTE) trials appear
Sign up with your email to follow new studies for VENOUS THROMBOEMBOLISM (VTE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot could stop deadly clots in cancer patients
Disease control Not yet recruitingThis study tests an experimental drug called REGN7508 for treating and preventing blood clots in people with cancer. About 1,600 participants will receive either REGN7508 or the standard blood thinner apixaban. The goal is to see if REGN7508 is safer and more effective at stoppin…
Matched conditions: VENOUS THROMBOEMBOLISM (VTE)
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 05:32 UTC
-
Old drug, new hope: colchicine trial aims to stop Post-Clot leg damage
Disease control Not yet recruitingThis study tests whether adding colchicine, an anti-inflammatory pill, to standard blood thinners can prevent long-term vein damage (post-thrombotic syndrome) in people with a first-time deep vein clot in the leg. About 940 adults will receive either colchicine or a placebo for o…
Matched conditions: VENOUS THROMBOEMBOLISM (VTE)
Phase: PHASE3 • Sponsor: Azienda Sanitaria Locale ASL 6, Livorno • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Hip fracture patients may soon swap painful injections for a daily aspirin
Disease control Not yet recruitingThis large study compares two common treatments to prevent blood clots in people who break their hip: aspirin tablets versus daily injections. Over 21,000 patients aged 60 and older across 96 UK hospitals will take part. Researchers will use NHS records to see which treatment is …
Matched conditions: VENOUS THROMBOEMBOLISM (VTE)
Phase: NA • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated May 04, 2026 16:30 UTC
-
New drug combo aims to cut heart attack risk after hip fracture
Disease control Not yet recruitingThis study tests whether a combination of two blood thinners (rivaroxaban and aspirin) can prevent heart attacks, strokes, and blood clots after hip fracture surgery in patients who had a heart injury. About 100 adults aged 45 and older will take either the combo for 90 days or s…
Matched conditions: VENOUS THROMBOEMBOLISM (VTE)
Phase: PHASE3 • Sponsor: McMaster University • Aim: Disease control
Last updated May 04, 2026 16:21 UTC
-
New Radiation-Free scan could spot dangerous lung clots in minutes
Diagnosis Not yet recruitingThis study is testing a new, non-invasive bedside scan called 3D-EIT to see if it can accurately diagnose and monitor pulmonary embolism (blood clots in the lungs) without using radiation. Researchers will compare the scan results to standard CT scans in 115 adults with and witho…
Matched conditions: VENOUS THROMBOEMBOLISM (VTE)
Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Diagnosis
Last updated May 08, 2026 12:03 UTC
-
Groundbreaking trial aims to prevent blood clots in critically ill teens
Prevention Not yet recruitingThis study tests whether the blood thinner enoxaparin can prevent blood clots in critically ill teenagers in the intensive care unit. About 802 teens at high risk for clots will receive either enoxaparin or a placebo. The goal is to see if the drug reduces clot risk without causi…
Matched conditions: VENOUS THROMBOEMBOLISM (VTE)
Phase: PHASE3 • Sponsor: Johns Hopkins All Children's Hospital • Aim: Prevention
Last updated May 15, 2026 11:57 UTC
-
New moms get video relief before needle: study
Symptom relief Not yet recruitingThis study tests if watching a short educational video before getting a blood thinner injection (LMWH) after childbirth can reduce anxiety and pain. About 160 new mothers will either get the usual explanation or also watch the video. The goal is to see if the video helps them fee…
Matched conditions: VENOUS THROMBOEMBOLISM (VTE)
Phase: NA • Sponsor: Wolfson Medical Center • Aim: Symptom relief
Last updated May 13, 2026 15:59 UTC
-
Can virtual care tech cut hospital falls and infections? duke launches massive study
Knowledge-focused Not yet recruitingThis study will see if using virtual care technologies in hospital units can reduce problems like patient falls, infections, and readmissions, while also improving patient satisfaction and length of stay. About 10,000 adults admitted to one of six hospital units at Duke Universit…
Matched conditions: VENOUS THROMBOEMBOLISM (VTE)
Sponsor: Duke University • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC